Obstetrics, gynecology and reproductive medicine guidelines

Anemia and hemoglobinopathies

PubMed Free Full Text

Anemia in kidney disease

Europe

• Nephrology Dialysis Transplantation
  • Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP) [2009]

International

• Cochrane Library
  • Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients
  • Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
  • Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients

• Kidney Disease: Improving Global Outcomes
  • KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease [2012]

• National Guideline Clearinghouse
  • KDIGO clinical practice guideline for anemia in chronic kidney disease [2012]

Italy

• Società Italiana di Ematologia
  • Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation [2011]

United Kingdom

• National Guideline Clearinghouse
  • Anaemia management in people with chronic kidney disease. National Clinical Guideline Centre for Acute and Chronic Conditions [2011]

• National Institute for Health and Clinical Excellence
  • Anaemia management in people with chronic kidney disease - NICE Pathways [2011]
  • Anaemia management in people with chronic kidney disease [2011]

• Royal College of Physicians
  • Anaemia management in chronic kidney disease. National clinical guideline for management in adults and children [2006]

United States of America

• National Guideline Clearinghouse
  • (1) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. (2) 2007 update of hemoglobin target. National Kidney Foundation [2007]

• National Kidney Foundation
  • Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease [2006]

Articles in journals

• American Journal of Nephrology
  • Hemoglobin Level Variability: Anemia Management among Variability Groups [2009]

• Archives of Internal Medicine
  • The Impact of Selecting a High Hemoglobin Target Level on Health-Related Quality of Life for Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis [2009]

• Clinical and Vaccine Immunology
  • Current Methods for Detecting Antibodies against Erythropoietin and Other Recombinant Proteins [2005]

• Clinical Journal of the American Society of Nephrology
  • Posttransplantation Anemia: Mechanisms and Management [2011]
  • Bundled-Rate Legislation for Medicare Reimbursement for Dialysis Services: Implications for Anemia Management with ESAs [2010]
  • Parenteral Iron Compounds: Potent Oxidants but Mainstays of Anemia Management in Chronic Renal Disease [2006]
  • Do We Know the Correct Hemoglobin Target for Anemic Patients with Chronic Kidney Disease? [2006]
  • Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation [2006]

• Clinical Medicine & Research
  • Safety Issues With Intravenous Iron Products in the Management of Anemia in Chronic Kidney Disease [2008]

• International Urology and Nephrology
  • Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD [2012]

• Journal of the American Society of Nephrology
  • Update on Erythropoietin Treatment: Should Hemoglobin Be Normalized in Patients with Chronic Kidney Disease? [2006]

• Kidney International
  • Iron-Refractory Iron Deficiency Anemia: New Molecular Mechanisms [2009]

• Nephrology Dialysis Transplantation
  • Optimal Treatment of Anemia in Nephrology Outcome of the OPTA (OPtimal Treatment of Anemia) working groups [2007]
  • Erythropoiesis-stimulating agents: Treating the anaemia of chronic kidney disease [2007]

• Nephron Clinical Practice
  • Anaemia Management in Non-Dialysis Chronic Kidney Disease: Flexibility of Target to Target Stability? [2010]

• Oncologist
  • Update on Anemia Management in Nephrology, Including Current Guidelines on the Use of Erythropoiesis-Stimulating Agents and Implications of the Introduction of "Biosimilars" [2009]
  • Is Nephrology More at Ease Than Oncology with Erythropoiesis-Stimulating Agents? Treatment Guidelines and an Update on Benefits and Risks [2009]
  • Iron Metabolism, Iron Deficiency, Thrombocytosis, and the Cardiorenal Anemia Syndrome [2009]
  • An Update on Twenty Years of Anemia Management with Erythropoiesis-Stimulating Agents in Nephrology and Oncology/Hematology [2009]

{Related topics}

• Guidelines
  • Anemia